Blog
IFI Insights: Anti-obesity drugs – which pharmaceuticals carry the most patent weight?
The growing success of GLP-1 agonists in treating obesity has ignited a gold rush among pharmaceuticals and biotechs. Such medical…
Blog
-
-
BlogIFI Insights: Challenging Nvidia – Examining the patents of an emerging AI chip company
Developing tools for generative AI demands enormous processing capacity. Nvidia’s chips sit at the top of that tech stack, and… -
BlogThe IFI Interview: Stephen Carter and Christian Hafner
The distance between having an idea and bringing it to market is long and difficult. RightHub’s mission goes beyond just… -
BlogIFI CLAIMS Technology Spotlight: Cybersecurity
The digital world is becoming more dangerous. The rise in internet-based threats around the globe has corporations and governments looking… -
BlogThe IFI Interview: Lewis Lee, Founder and CEO of Moat Metrics
Valuing IP is an industry holy grail. Creating an exchange to buy and sell it has long been considered the… -
BlogIFI CLAIMS Technology Spotlight: Semiconductors
A global race is underway to lead in semiconductors—in both manufacturing capability and cutting-edge performance. With billions of dollars pouring… -
BlogIFI CLAIMS Technology Spotlight: Quantum computing
Traditional, transistor-centered computers have certainly revolutionized the world. But there is only so much that classic computing can do. Not… -
BlogThe IFI Deal: Walmart goes shopping for Vizio
When the news broke earlier this year that Walmart sought to purchase smart television maker Vizio for $2.3 billion, analysts… -
BlogIFI CLAIMS Technology Spotlight: AI and the real estate sector
Location, location, location is the most important rule of real estate. Comparable properties can have widely divergent values based on… -
BlogIFI Insights: Opening the patent picture on Generative AI
2023 was a year-long bash for artificial intelligence. The guest of honor at the party? Generative AI, in the form… -
BlogThe IFI Deal: GE HealthCare acquisitions from the patent point of view
Breaking up a conglomerate is hard to do, but GE successfully spun off its healthcare business early this year. GE… -
BlogThe IFI Interview: Making patents usable with Matthias Poetzl and Michael Natterer of Dennemeyer Octimine
Traditional patent tools are for traditional IP professionals who have expertise in dealing with the complications of patent data. Octimine…